Ubiquigent
Ubiquigent is a company that focuses on drug discovery and development through the study of deubiquitinases (DUBs) and the ubiquitin-proteasome system (UPS). They have a platform that supports the design and discovery of DUB-targeting compounds for the development of therapeutics.
- DUB-targeting compounds
- High-quality research reagents
- End-to-end drug discovery platform
- Specialist services for DUB-focused research
Locations
Digital Popularity
Social Media
LinkedIn1,205 Followers
Competitors
Platinum Discovery is a research partner specialising in multiomics solutions for precision medicine.
Ten Bio is an internationally trusted research partner dedicated to advancing skin research through innovative solutions.
Company Details
Ubiquigent is operated by Ubiquigent Ltd and is a Active company incorporated on 10 July 2009 with the registered office located in Dundee, City of Dundee. Ubiquigent Ltd was registered 16 years ago.
Status
Active
Size
Small
Directors
6
Age
16 years old
Employees
12
Turnover
Unreported
Total Assets
£760.29K
Cash in Bank
£186.49K
Total Liabilities
-£218.69K
Teams
8
4
4
3
Chief Executive Officer • Joined Jun 2021
Non Executive Director • Joined Aug 2015
Principal Scientist • Joined Nov 2021
Head Of Biology • Joined Jul 2018
Head Of Chemistry • Joined Jul 2023
Head Of Business Development • Joined Oct 2022
Chairperson • Joined Sep 2013
Senior Scientist • Joined Sep 2019
Principal Scientist • Joined Nov 2021
Head Of Biology • Joined Jul 2018
Head Of Chemistry • Joined Jul 2023
Senior Scientist • Joined Sep 2019
Chief Executive Officer • Joined Jun 2021
Non Executive Director • Joined Aug 2015
Chief Scientific Officer • Joined Jun 2021
Chairperson • Joined Sep 2013
Chief Executive Officer • Joined Jun 2021
Head Of Business Development • Joined Oct 2022
Chairperson • Joined Sep 2013